Every SKU earns its place — or explains why it stays. X-ray the portfolio.
Every SKU earns its place or explains why it stays. Enter sales, contribution, growth and stock turns; the X-Ray groups the portfolio into heroes, fixes, maintainers and retire-review candidates — with strategic SKUs protected from the axe.
| SKU | Net sales ₹ | Contrib. % | Growth % | Stock turns | Strategic? |
|---|---|---|---|---|---|
SKUs are grouped by revenue share (meaningful vs tail) against portfolio-average contribution: big-and-healthy = hero; big-but-thin = fix; small-but-healthy = maintain; small-and-thin = retire-review.
Strategic-role SKUs (channel entry, bundle anchors) go to 'investigate' with their rationale required — the tool never auto-kills.
Stock turns expose inventory burden: a tail SKU with 1 turn ties up cash even if its margin looks acceptable.
Illustrative figures, not a client outcome.
Twice a year for stable categories, quarterly for fast ones. Portfolio creep is silent — you notice it in warehouse cost before in sales.
Growth changes the grouping — a fast-growing tail SKU with decent margin is tomorrow's hero. The growth column exists exactly for that.
Version 1.0 · Reviewed 2026-10 · Methodology is fixed and version-controlled; results depend on your inputs.
Portfolio X-rayed. Now rationalise without losing the strategic bets.
BLEZZINGS runs this analysis inside a focused engagement — with your data, your market and a plan to act on it.